Stay updated with breaking news from Evan Masingill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Supreme Court on Wednesday extended for two days a pause on a lower-court ruling that had sought to limit access to the abortion pill mifepristone, ensuring that the drug would continue to remain widely available for now.
The Supreme Court is considering whether to maintain a court order that would severely restrict access to the abortion drug mifepristone.
A company that makes the generic abortion pill filed a lawsuit against the FDA Wednesday to prevent the agency from ordering mifepristone off the market.
The suit by GenBioPro, the generic maker of mifepristone, is the latest strand in the intense legal battle over abortion pills.
Less than a year after the Supreme Court declared it was ceding the matter of abortion to elected officials, the justices are poised to consider whether the most common method of ending pregnancies can be sharply curtailed, even in states where abortion remains legal.